NOMAD POWER SOLUTIONS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $1.10M.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $1.00.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $45.80K.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-12-31 was $0.00.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $45.80K.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $6.28K.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $201.00K.
- NOMAD POWER SOLUTIONS, INC. stock issued during period, value, stock options exercised for fiscal 2018 was $3.00K, a 83.33% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $1.10M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $45.80K 10-K · filed 2026-03-31 |
| 2025-09-30 | $45.80K 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $6.28K 10-K · filed 2025-03-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | |
| 2023-03-31 | $6.28K 10-Q · filed 2024-05-09 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $201.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $101.00K 10-Q · filed 2021-08-10 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $3.00K 10-K · filed 2020-03-25 |
| 2018-09-30 | $3.00K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $18.00K 10-K · filed 2019-03-25 |
| 2012-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-09 | $33.33K 10-Q · filed 2014-05-09 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $33.33K derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $33.33K derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-03-31 | $33.33K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2014-05-09 | $5.00K 10-Q · filed 2014-05-09 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |